Can Semaglutide reduce the risk of Alzheimer’s? A new study offers hope of a therapy option
Semaglutide, the blood sugar control and weight loss drug, has another added benefit. A recent study, published in Alzheimer’s & Dementia, shows that it can reduce the risk of Alzheimer’s Disease in people with Type 2 diabetes.
Researchers at Case Western Reserve School of Medicine have found that, when compared to seven other anti-diabetic drugs, ...
People with type 2 diabetes who use semaglutide drugs like Ozempic and Wegovy appear to have a lower risk of Alzheimer's ...
Oral semaglutide improved liver health, diabetes status, and lipid profile in patients with MASLD and T2D, with weight loss ...
A new study is adding to evidence that GLP-1 drugs such as Novo Nordisk's semaglutide and Eli Lilly's tirzepatide could also ...
According to new data from the SOUL trial Oral semaglutide reduced MACE by 14% in Type 2 Diabetes patients. Novo Nordisk will ...
Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with ...
HealthDay on MSN16h
Duodenal ReCET Plus Semaglutide Can Prevent Need for Insulin in T2DMFor patients with type 2 diabetes (T2D), duodenal recellularization via electroporation therapy (ReCET), which uses pulsed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback